Related references
Note: Only part of the references are listed.Shared and Distinct Brain Regions Targeted for Immediate Early Gene Expression by Ketamine and Psilocybin
Pasha A. Davoudian et al.
ACS Chemical Neuroscience (2023)
5-HT2ARs Mediate Therapeutic Behavioral Effects of Psychedelic Tryptamines
Lindsay P. Cameron et al.
ACS CHEMICAL NEUROSCIENCE (2023)
Psychedelics
Benjamin Kelmendi et al.
CURRENT BIOLOGY (2022)
The clinical pharmacology and potential therapeutic applications of 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT)
Johannes T. Reckweg et al.
JOURNAL OF NEUROCHEMISTRY (2022)
A narrative synthesis of research with 5-MeO-DMT
Anna O. Ermakova et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2022)
Structure-based discovery of nonhallucinogenic psychedelic analogs
Dongmei Cao et al.
SCIENCE (2022)
5-HT2A SNPs Alter the Pharmacological Signaling of Potentially Therapeutic Psychedelics
Gavin P. Schmitz et al.
ACS CHEMICAL NEUROSCIENCE (2022)
Bespoke library docking for 5-HT2A receptor agonists with antidepressant activity
Anat Levit Kaplan et al.
NATURE (2022)
The neural basis of psychedelic action
Alex C. Kwan et al.
NATURE NEUROSCIENCE (2022)
A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT2A Receptor Density in the Pig Brain
Nakul Ravi Raval et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
A non-hallucinogenic psychedelic analogue with therapeutic potential
Lindsay P. Cameron et al.
NATURE (2021)
Structure and function of a neocortical synapse
Simone Holler et al.
NATURE (2021)
A Dendrite-Focused Framework for Understanding the Actions of Ketamine and Psychedelics
Neil K. Savalia et al.
TRENDS IN NEUROSCIENCES (2021)
Prolonged epigenomic and synaptic plasticity alterations following single exposure to a psychedelic in mice
Mario de la Fuente Revenga et al.
CELL REPORTS (2021)
A Phase 1, Dose-Ranging Study to Assess Safety and Psychoactive Effects of a Vaporized 5-Methoxy-N, N-Dimethyltryptamine Formulation (GH001) in Healthy Volunteers
Johannes Reckweg et al.
FRONTIERS IN PHARMACOLOGY (2021)
Trial of Psilocybin versus Escitalopram for Depression
Robin Carhart-Harris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice
Natalie Hesselgrave et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Analysis of ultrasonic vocalizations from mice using computer vision and machine learning
Antonio H. O. Fonseca et al.
ELIFE (2021)
Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder A Randomized Clinical Trial
Alan K. Davis et al.
JAMA PSYCHIATRY (2021)
Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo
Ling-Xiao Shao et al.
NEURON (2021)
The role of the periaqueductal gray in escape behavior
Yaara Lefler et al.
CURRENT OPINION IN NEUROBIOLOGY (2020)
Identification of Psychoplastogenic N,N-Dimethylaminoisotryptamine (isoDMT) Analogues through Structure-Activity Relationship Studies
Lee E. Dunlap et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Automated quantification of head-twitch response in mice via ear tag reporter coupled with biphasic detection
Mario de la Fuente Revenga et al.
JOURNAL OF NEUROSCIENCE METHODS (2020)
SciPy 1.0: fundamental algorithms for scientific computing in Python
Pauli Virtanen et al.
NATURE METHODS (2020)
Psychedelic Psychiatry's Brave New World
David Nutt et al.
CELL (2020)
Anxiety-like behavior induced by salicylate depends on age and can be prevented by a single dose of 5-MeO-DMT
Jessica Winne et al.
EXPERIMENTAL NEUROLOGY (2020)
Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species
Adam L. Halberstadt et al.
NEUROPHARMACOLOGY (2020)
Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders
Franz X. Vollenweider et al.
NATURE REVIEWS NEUROSCIENCE (2020)
Synthesis and Characterization of 5-MeO-DMT Succinate for Clinical Use
Alexander M. Sherwood et al.
ACS OMEGA (2020)
5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) used in a naturalistic group setting is associated with unintended improvements in depression and anxiety
Alan K. Davis et al.
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE (2019)
A single inhalation of vapor from dried toad secretion containing 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting is related to sustained enhancement of satisfaction with life, mindfulness-related capacities, and a decrement of psychopathological symptoms
M. V. Uthaug et al.
PSYCHOPHARMACOLOGY (2019)
A Specialized Neural Circuit Gates Social Vocalizations in the Mouse
Katherine Tschida et al.
NEURON (2019)
Lower synaptic density is associated with depression severity and network alterations
Sophie E. Holmes et al.
NATURE COMMUNICATIONS (2019)
Ultrasonic vocalization sex differences in 5-HT1A-R deficient mouse pups: Predictive phenotypes associated with later-life anxiety-like behaviors
Tatyana Budylin et al.
BEHAVIOURAL BRAIN RESEARCH (2019)
Sustained rescue of prefrontal circuit dysfunction by antidepressant-induced spine formation
R. N. Moda-Sava et al.
SCIENCE (2019)
The epidemiology of 5-methoxy-N, N-dimethyltryptamine (5-MeO-DMT) use: Benefits, consequences, patterns of use, subjective effects, and reasons for consumption
Alan K. Davis et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2018)
Psychedelics Promote Structural and Functional Neural Plasticity
Calvin Ly et al.
CELL REPORTS (2018)
A Single Dose of 5-MeO-DMT Stimulates Cell Proliferation, Neuronal Survivability, Morphological and Functional Changes in Adult Mice Ventral Dentate Gyrus
Rafael Vitor Lima da Cruz et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2018)
The temporal organization of mouse ultrasonic vocalizations
Gregg A. Castellucci et al.
PLOS ONE (2018)
Intensity of Mystical Experiences Occasioned by 5-MeO-DMT and Comparison With a Prior Psilocybin Study
Joseph Barsuglia et al.
FRONTIERS IN PSYCHOLOGY (2018)
Serotonin and brain function: a tale of two receptors
R. L. Carhart-Harris et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2017)
Potential Therapeutic Effects of Psilocybin
Matthew W. Johnson et al.
NEUROTHERAPEUTICS (2017)
Short term changes in the proteome of human cerebral organoids induced by 5-MeO-DMT
Vanja Dakic et al.
SCIENTIFIC REPORTS (2017)
Longitudinal Effects of Ketamine on Dendritic Architecture In Vivo in the Mouse Medial Frontal Cortex
Victoria Phoumthipphavong et al.
ENEURO (2016)
Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study
Robin L. Carhart-Harris et al.
LANCET PSYCHIATRY (2016)
Female mice ultrasonically interact with males during courtship displays
Joshua P. Neunuebel et al.
ELIFE (2015)
The natural hallucinogen 5-MeO-DMT, component of Ayahuasca, disrupts cortical function in rats: reversal by antipsychotic drugs
Maurizio S. Riga et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2014)
Cocaine-induced structural plasticity in frontal cortex correlates with conditioned place preference
Francisco Javier Munoz-Cuevas et al.
NATURE NEUROSCIENCE (2013)
Characterization of the head-twitch response induced by hallucinogens in mice Detection of the behavior based on the dynamics of head movement
Adam L. Halberstadt et al.
PSYCHOPHARMACOLOGY (2013)
NIH Image to ImageJ: 25 years of image analysis
Caroline A. Schneider et al.
NATURE METHODS (2012)
Glutamate N-methyl-D-aspartate Receptor Antagonists Rapidly Reverse Behavioral and Synaptic Deficits Caused by Chronic Stress Exposure
Nanxin Li et al.
BIOLOGICAL PSYCHIATRY (2011)
Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice
Adam L. Halberstadt et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Psychedelic 5-Methoxy-N,N-Dimethyltryptamine: Metabolism, Pharmacokinetics, Drug Interactions, and Pharmacological Actions
Hong-Wu Shen et al.
CURRENT DRUG METABOLISM (2010)
Psychedelics and the Human Receptorome
Thomas S. Ray
PLOS ONE (2010)
mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
Nanxin Li et al.
SCIENCE (2010)
Long-term, high-resolution imaging in the mouse neocortex through a chronic cranial window
Anthony Holtmaat et al.
NATURE PROTOCOLS (2009)
Rapid modulation of spine morphology by the 5-HT2A serotonin receptor through kalirin-7 signaling
Kelly A. Jones et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Glutamatergic and GABAergic modulations of ultrasonic vocalizations during maternal separation distress in mouse pups
Aki Takahashi et al.
PSYCHOPHARMACOLOGY (2009)
Stress-induced alterations in prefrontal cortical dendritic morphology predict selective impairments in perceptual attentional set-shifting
Conor Liston et al.
JOURNAL OF NEUROSCIENCE (2006)
Repeated stress induces dendritic spine loss in the rat medial prefrontal cortex
JJ Radley et al.
CEREBRAL CORTEX (2006)
Ultrasonic songs of male mice
TE Holy et al.
PLOS BIOLOGY (2005)
Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose-effect study
F Hasler et al.
PSYCHOPHARMACOLOGY (2004)
Structure-stability-function relationships of dendritic spines
H Kasai et al.
TRENDS IN NEUROSCIENCES (2003)
Neural pathways underlying vocal control
U Jurgens
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2002)
Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP
GP Feng et al.
NEURON (2000)
Ethanol inhibits development of dendrites and synapses in rat hippocampal pyramidal neuron cultures
PA Yanni et al.
DEVELOPMENTAL BRAIN RESEARCH (2000)
Distress vocalizations in maternally separated mouse pups:: modulation via 5-HT1A, 5-HT1B and GABAA receptors
EW Fish et al.
PSYCHOPHARMACOLOGY (2000)
The paradox of 5-methoxy-N,N-dimethyltryptamine: An indoleamine hallucinogen that induces stimulus control via 5-HT1A receptors
JC Winter et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2000)
Share Paper
